deltatrials
Recruiting PHASE1 INTERVENTIONAL 2-arm NCT04697576

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Intralesional Influenza Vaccine for Patients With Melanoma

Sponsor: Carlo Contreras

Updated 9 times since 2021 Last updated: Mar 7, 2026 Started: Oct 20, 2021 Primary completion: Sep 30, 2027 Completion: Dec 31, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04697576, this PHASE1 trial focuses on Clinical Stage I Cutaneous Melanoma AJCC v8 and Clinical Stage IA Cutaneous Melanoma AJCC v8 and remains actively recruiting participants. Sponsored by Carlo Contreras, it has been updated 9 times since 2021, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Feb 2021 – ~Oct 2021 · 8 months · monthly snapshotNot Yet Recruiting~Oct 2021 – ~May 2022 · 7 months · monthly snapshotRecruiting~May 2022 – ~Aug 2023 · 15 months · monthly snapshotRecruiting~Aug 2023 – ~Jul 2024 · 11 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Nov 2024 · 2 months · monthly snapshot~Nov 2024 – ~Aug 2025 · 9 months · monthly snapshotRecruiting~Aug 2025 – ~Mar 2026 · 7 months · monthly snapshotRecruiting~Mar 2026 – present · 5 months · monthly snapshotRecruiting

Change History

9 versions recorded
  1. Mar 2026 — Present [monthly]

    Recruiting PHASE1

  2. Aug 2025 — Mar 2026 [monthly]

    Recruiting PHASE1

  3. Nov 2024 — Aug 2025 [monthly]

    Recruiting PHASE1

  4. Sep 2024 — Nov 2024 [monthly]

    Recruiting PHASE1

  5. Jul 2024 — Sep 2024 [monthly]

    Recruiting PHASE1

Show 4 earlier versions
  1. Aug 2023 — Jul 2024 [monthly]

    Recruiting PHASE1

  2. May 2022 — Aug 2023 [monthly]

    Recruiting PHASE1

  3. Oct 2021 — May 2022 [monthly]

    Recruiting PHASE1

    Status: Not Yet RecruitingRecruiting

  4. Feb 2021 — Oct 2021 [monthly]

    Not Yet Recruiting PHASE1

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Carlo Contreras
Data source: Ohio State University Comprehensive Cancer Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations